The emerging therapy of this peptide represents a exciting breakthrough in the management of the condition. Unlike existing therapies, tirzepatide targets two pathways – glucagon-like peptide-1 (GLP-1) and GIP – https://tirzepatidepeptide774360.develop-blog.com/49945757/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment